Three Firms Steer Sobi's $915M Dova Pharma Buy
Biopharmaceutical company Swedish Orphan Biovitrum said Monday that it has agreed to buy a clinical stage pharmaceutical company in a deal steered by Cravath Swaine & Moore, Mannheimer Swartling Advokatbyrå and...To view the full article, register now.
Already a subscriber? Click here to view full article